IBI Journal@IbiJournal

IBI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

 London
international-biopharma.com/
Joined September 2019
Managing the Transition to Next-generation Sequencing international-biopharma.com/…

Managing the Transition to Next-generation Sequencing - International Biopharmaceutical Industry

Dr. Ģirts Šķenders and Mr. Reinis Zeltmatis shed light on how the COVID-19 pandemic brought significant changes to their hospital laboratory. Upgrading it in

international-biopharma.com
Preparing for Success – How to have a positive FDA Inspection international-biopharma.com/…

Preparing for Success – How to have a positive FDA Inspection - International Biopharmaceutical...

Success does not come about by coincidence. Success is an outcome of preparation. When it comes to successful U.S. Food and Drug Administration (FDA)

international-biopharma.com
Ensuring Success in Pharmacovigilance and Patient Safety international-biopharma.com/…

Ensuring Success in Pharmacovigilance and Patient Safety - International Biopharmaceutical Industry

Best practices for sponsor and CRO alliances in a demanding industry

international-biopharma.com
Integrated Laboratory Informatics – Are Organisations Really Exploiting the Benefits? international-biopharma.com/…

Integrated Laboratory Informatics – Are Organisations Really Exploiting the Benefits? - Internati...

The ideas behind integrated laboratory informatics are not new, but there are serious questions as to how many organisations are fully, or even partially,

international-biopharma.com
SLP’s Use in the Pharmaceutical World international-biopharma.com/…
Trends Paving the Way for an Influx of Biosimilar Development international-biopharma.com/…

Trends Paving the Way for an Influx of Biosimilar Development - International Biopharmaceutical...

Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator

international-biopharma.com
How do we Address Product Finishing and Dispensing Challenges for Future Pandemics? international-biopharma.com/…

How do we Address Product Finishing and Dispensing Challenges for Future Pandemics? - International...

The refinement of sterile manufacturing processes had a central part to play in enabling the pharmaceutical industry to successfully deliver billions of doses

international-biopharma.com
How Do You Build an AAV Manufacturing Platform? international-biopharma.com/…

How Do You Build an AAV Manufacturing Platform? - International Biopharmaceutical Industry

Gene therapy represents an expanding area of medicine with the potential to change the lives of people with life-limiting conditions. As the interest in gene

international-biopharma.com
Strategies to Reduce Cold Chain Burden in Biopharmaceuticals international-biopharma.com/…

Strategies to Reduce Cold Chain Burden in Biopharmaceuticals - International Biopharmaceutical...

The availability of a wide range of therapeutic biologics has revolutionised modern medicine. Whilst the majority of pharmaceutical drug products remain

international-biopharma.com
Looking Beyond Plasmids: What’s on the Horizon for Gene Therapy Manufacture? international-biopharma.com/…
Strategies for Simplifying Biopharma’s Digital Journey international-biopharma.com/…

Strategies for Simplifying Biopharma’s Digital Journey - International Biopharmaceutical Industry

The biopharma industry requires digital transformations to improve efficiencies and deliver critical therapeutics to patients at an accelerated rate. Although

international-biopharma.com
Technological Advancements Support RNA and Oligonucleotide Sequence Confirmation international-biopharma.com/…

Technological Advancements Support RNA and Oligonucleotide Sequence Confirmation - International...

Advancements in gene therapy and the approval of mRNA vaccines have dramatically increased the demand for well-characterised RNA and oligonucleotides in the

international-biopharma.com
Advancing Drug Discovery by Connecting the Community international-biopharma.com/…

Advancing Drug Discovery by Connecting the Community - International Biopharmaceutical Industry

Over 1500 life science professionals attended the Drug Discovery 2022 conference this year. Organised by ELRIG – leaders in the provision of scientific

international-biopharma.com
CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again international-biopharma.com/…

CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again - International...

In-person visitor numbers rebound sharply, with record C-Suite attendance and the largest-ever online presence.

international-biopharma.com
1
Pfizer lures research chief from Roche, prompting high-level reshuffle international-biopharma.com/…

Pfizer lures research chief from Roche, prompting high-level reshuffle - International Biopharmac...

The move thrusts Pao even more into the spotlight given his new role will involve supporting two of the highest-profile pharmaceutical products in the world,

international-biopharma.com
Novo Nordisk to boost drug manufacturing in Denmark international-biopharma.com/…

Novo Nordisk to boost drug manufacturing in Denmark - International Biopharmaceutical Industry

Danish drugmaker Novo Nordisk will spend 5.4 billion Danish kroner, or about $744 million, to expand its clinical manufacturing facilities in a suburb near

international-biopharma.com
FDA approves first gene therapy for hemophilia B international-biopharma.com/…
Teva taps Sandoz veteran to take over CEO post from Schultz international-biopharma.com/…
Merck to buy blood cancer biotech Imago for $1.35B international-biopharma.com/…

Merck to buy blood cancer biotech Imago for $1.35B - International Biopharmaceutical Industry

Merck & Co. has agreed to acquire Imago BioSciences, a California-based biotechnology company focused on bone marrow disorders, for more than $1 billion

international-biopharma.com
GSK to pull blood cancer drug from US market after study failure international-biopharma.com/…

GSK to pull blood cancer drug from US market after study failure - International Biopharmaceutical...

GSK will pull a blood cancer drug from the U.S. market after the treatment failed in a confirmatory clinical trial, the British drugmaker announced Tuesday.

international-biopharma.com
Load more